Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Mar 20, 2021 5:23pm
217 Views
Post# 32845672

MEDV must PIVOT away from covid19 testing....

MEDV must PIVOT away from covid19 testing....During the webinar Doug must clearly demontrate with credible and realistic timelines how MEDV intends to pivot away from covid19 testing as investors are NOT going to give any sort of premium for this market.

You cannot sustain yourself in a dying market which is quickly going away.    Isreal is proving that if you vaccinate everyone, the number of cases and deaths drop to minimal amounts that makes testing unnecessary.

If the vaccine was not around, then testing would be critical.    But we have the vaccine so no one will want to get tested anymore. 

If Doug fails to pivot then MEDV is done as there is no exit door from a dying market.   I thought they were smart enough to plan ahead but instead find themselves chasing the market. 

Lets hope that he can rectify the mountain of errors he has created and that he stops lying about how many cubes are going to be opened.  We know that the projections he made to investors were all false promises. 

I have no issue with him but he does make life very difficult for shareholders to be able to trust in him when he keeps breaking his promises (ie:  number of cubes  + to use factoring and then boom a bought deal + Karland).

Good Luck to everyone

MPO
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse